Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2012 1
2013 1
2019 2
2020 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Anti-CD44 DNA Aptamers Selectively Target Cancer Cells.
Pęcak A, Skalniak Ł, Pels K, Książek M, Madej M, Krzemień D, Malicki S, Władyka B, Dubin A, Holak TA, Dubin G. Pęcak A, et al. Nucleic Acid Ther. 2020 Oct;30(5):289-298. doi: 10.1089/nat.2019.0833. Epub 2020 May 6. Nucleic Acid Ther. 2020. PMID: 32379519
Development of a novel, high-affinity ssDNA trypsin inhibitor.
Malicki S, Ksiazek M, Majewski P, Pecak A, Mydel P, Grudnik P, Dubin G. Malicki S, et al. Among authors: pecak a. J Enzyme Inhib Med Chem. 2019 Dec;34(1):638-643. doi: 10.1080/14756366.2019.1569648. J Enzyme Inhib Med Chem. 2019. PMID: 30727784 Free PMC article.
Development of Chemical Tools to Monitor Human Kallikrein 13 (KLK13) Activity.
Gruba N, Bielecka E, Wysocka M, Wojtysiak A, Brzezińska-Bodal M, Sychowska K, Kalińska M, Magoch M, Pęcak A, Falkowski K, Wiśniewska M, Sąsiadek L, Płaza K, Kroll E, Pejkovska A, Rehders M, Brix K, Dubin G, Kantyka T, Potempa J, Lesner A. Gruba N, et al. Among authors: pecak a. Int J Mol Sci. 2019 Mar 28;20(7):1557. doi: 10.3390/ijms20071557. Int J Mol Sci. 2019. PMID: 30925705 Free PMC article.
Kallikrein-Related Peptidase 14 Activates Zymogens of Membrane Type Matrix Metalloproteinases (MT-MMPs)-A CleavEx Based Analysis.
Falkowski K, Bielecka E, Thøgersen IB, Bocheńska O, Płaza K, Kalińska M, Sąsiadek L, Magoch M, Pęcak A, Wiśniewska M, Gruba N, Wysocka M, Wojtysiak A, Brzezińska-Bodal M, Sychowska K, Pejkovska A, Rehders M, Butler G, Overall CM, Brix K, Dubin G, Lesner A, Kozik A, Enghild JJ, Potempa J, Kantyka T. Falkowski K, et al. Among authors: pecak a. Int J Mol Sci. 2020 Jun 19;21(12):4383. doi: 10.3390/ijms21124383. Int J Mol Sci. 2020. PMID: 32575583 Free PMC article.
Mdm2 and MdmX inhibitors for the treatment of cancer: a patent review (2011-present).
Zak K, Pecak A, Rys B, Wladyka B, Dömling A, Weber L, Holak TA, Dubin G. Zak K, et al. Among authors: pecak a. Expert Opin Ther Pat. 2013 Apr;23(4):425-48. doi: 10.1517/13543776.2013.765405. Epub 2013 Feb 4. Expert Opin Ther Pat. 2013. PMID: 23374098 Review.
On the mechanism of action of SJ-172550 in inhibiting the interaction of MDM4 and p53.
Bista M, Smithson D, Pecak A, Salinas G, Pustelny K, Min J, Pirog A, Finch K, Zdzalik M, Waddell B, Wladyka B, Kedracka-Krok S, Dyer MA, Dubin G, Guy RK. Bista M, et al. Among authors: pecak a. PLoS One. 2012;7(6):e37518. doi: 10.1371/journal.pone.0037518. Epub 2012 Jun 4. PLoS One. 2012. PMID: 22675482 Free PMC article.
Interaction of regulators Mdm2 and Mdmx with transcription factors p53, p63 and p73.
Zdzalik M, Pustelny K, Kedracka-Krok S, Huben K, Pecak A, Wladyka B, Jankowski S, Dubin A, Potempa J, Dubin G. Zdzalik M, et al. Among authors: pecak a. Cell Cycle. 2010 Nov 15;9(22):4584-91. doi: 10.4161/cc.9.22.13871. Epub 2010 Nov 15. Cell Cycle. 2010. PMID: 21088494
High affinity interaction of the p53 peptide-analogue with human Mdm2 and Mdmx.
Czarna A, Popowicz GM, Pecak A, Wolf S, Dubin G, Holak TA. Czarna A, et al. Among authors: pecak a. Cell Cycle. 2009 Apr 15;8(8):1176-84. doi: 10.4161/cc.8.8.8185. Epub 2009 Apr 16. Cell Cycle. 2009. PMID: 19305137
Feedback